A carregar...
Adherence, Dosing, and Managing Toxicities With Trifluridine/Tipiracil (TAS-102)
Trifluridine/tipiracil (TAS-102) is a new oral combination therapy approved by the US Food and Drug Administration for the treatment of patients with metastatic colorectal cancer who are refractory to or intolerant of standard chemotherapy. This agent consists of a thymidine-based nucleoside analog...
Na minha lista:
| Publicado no: | Clin Colorectal Cancer |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5743195/ https://ncbi.nlm.nih.gov/pubmed/28242161 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clcc.2017.01.003 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|